| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.10(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,133,553 |
| 52
Week Range: |
$4.32 - $9.78 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : 19.4 |
| Insider 6 Months : 19.4 |
| Insider 3/6 Months : 39.2 |
|
| Guru Rank Number : 661 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,788,608 |
2,788,608 |
2,788,608 |
2,788,608 |
| Total Buy Value |
$14,700,258 |
$14,700,258 |
$14,700,258 |
$14,700,258 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
3 |
3 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
13,810 |
27,071 |
| Total Sell Value |
$0 |
$0 |
$86,702 |
$205,872 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
6 |
| End Date |
2025-03-16 |
2024-12-13 |
2024-06-14 |
2023-06-15 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Paulson John |
|
• • – |
2025-06-12 |
4 |
B |
$5.47 |
$5,499,407 |
I/I |
1,005,376 |
29,227,643 |
0.01 |
9% |
|
| Paulson John |
|
• • – |
2025-06-11 |
4 |
B |
$5.24 |
$5,392,474 |
I/I |
1,029,098 |
28,222,267 |
0.01 |
12% |
|
| Paulson John |
|
• • – |
2025-06-10 |
4 |
B |
$5.05 |
$3,808,377 |
I/I |
754,134 |
27,193,169 |
0.01 |
17% |
|
| Power Robert N |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
254,723 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
263,355 |
|
- |
|
| Kavanagh Sarah B |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
236,359 |
|
- |
|
| Lee Frank D. |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
89,707 |
|
- |
|
| Mulligan Richard |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
155,616 |
|
- |
|
| Garcia Christian A |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
89,707 |
|
- |
|
| Paulson John |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
332,055 |
|
- |
|
| Miller Steven D |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
229,224 |
|
- |
|
| Icahn Brett |
Director |
• • – |
2025-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,347 |
216,246 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2025-03-31 |
4 |
A |
$6.47 |
$6,871 |
D/D |
1,062 |
209,008 |
|
- |
|
| Icahn Brett |
Director |
• • – |
2025-03-31 |
4 |
A |
$6.47 |
$33,120 |
D/D |
5,119 |
161,899 |
|
- |
|
| Paulson John |
Director |
• • – |
2025-03-31 |
4 |
A |
$6.47 |
$62,494 |
D/D |
9,659 |
277,708 |
|
- |
|
| Carson Seana |
EVP, General Counsel |
• • – |
2025-02-28 |
4 |
D |
$7.44 |
$366,732 |
D/D |
(49,292) |
564,292 |
|
- |
|
| Appio Thomas |
Chief Executive Officer |
• • – |
2025-02-28 |
4 |
D |
$7.44 |
$1,538,957 |
D/D |
(206,849) |
1,783,249 |
|
- |
|
| Barresi John S |
SVP, Controller & CAO |
• • – |
2025-02-28 |
4 |
D |
$7.44 |
$59,230 |
D/D |
(7,961) |
192,268 |
|
- |
|
| Barresi John S |
SVP, Controller & CAO |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
49,823 |
200,229 |
|
- |
|
| Appio Thomas |
Chief Executive Officer |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
635,425 |
1,990,098 |
|
- |
|
| Carson Seana |
EVP, General Counsel |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
180,518 |
613,584 |
|
- |
|
| Lenar Aimee J. |
EVP, US Pharma |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
108,311 |
252,663 |
|
- |
|
| Charhon Jean-Jacques |
EVP, CFO |
• • – |
2025-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
216,622 |
515,460 |
|
- |
|
| Icahn Brett |
Director |
• • – |
2024-12-31 |
4 |
A |
$8.06 |
$33,119 |
D/D |
4,109 |
156,780 |
|
- |
|
| Paulson John |
Director |
• • – |
2024-12-31 |
4 |
A |
$8.06 |
$62,497 |
D/D |
7,754 |
268,049 |
|
- |
|
652 Records found
|
|
Page 1 of 27 |
|
|
0.07 (1.17%) 
